(Q38243160)

31 August 2017

title

Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens (English)

1 reference

31 August 2017

Shih-Yeh Lin

1

1 reference

31 August 2017

Yao-Chi Chung

series ordinal

2

1 reference

31 August 2017

Yu-Chen Hu

series ordinal

3

1 reference

31 August 2017

publication date

26 August 2014

1 reference

Expert Review of Vaccines

31 August 2017

published in

1 reference

31 August 2017

volume

13

1 reference

31 August 2017

issue

12

1 reference

31 August 2017

page(s)

1501-1521

1 reference

Baculovirus expression systems for recombinant protein production in insect cells

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculoviral vectors for gene delivery: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Recombinant protein vaccines produced in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Insect cell technology is a versatile and robust vaccine manufacturing platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Insect cells as a production platform of complex virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Protein production using the baculovirus-insect cell expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Insect cells as a factory to produce adeno-associated virus type 2 vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus as a highly efficient expression vector in insect and mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

High-efficiency transient transduction of human embryonic stem cell-derived neurons with baculoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Glioma gene therapy using induced pluripotent stem cell derived neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

The role of adipose-derived stem cells engineered with the persistently expressing hybrid baculovirus in the healing of massive bone defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Human embryonic stem cell-derived mesenchymal stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus-transduced bone marrow mesenchymal stem cells for systemic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculoviral transduction facilitates TALEN-mediated targeted transgene integration and Cre/LoxP cassette exchange in human-induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

A graphene-based platform for induced pluripotent stem cells culture and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Efficient gene delivery into cell lines and stem cells using baculovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus gene delivery: a flexible assay development tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus as versatile vectors for protein expression in insect and mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Highly efficient baculovirus-mediated gene transfer into rat chondrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus as a highly efficient gene delivery vector for the expression of hepatitis delta virus antigens in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Modulation of chondrocyte phenotype via baculovirus-mediated growth factor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Development of a hybrid baculoviral vector for sustained transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Chromosomal integration of transduced recombinant baculovirus DNA in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Adaptive immune responses elicited by baculovirus and impacts on subsequent transgene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus-based vaccination vectors allow for efficient induction of immune responses against plasmodium falciparum circumsporozoite protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Maximizing baculovirus-mediated foreign proteins expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus expression of cloned porcine arterivirus generates infectious particles in both insect and mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus for eukaryotic protein display

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Potential cancer gene therapy by baculoviral transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Development of the hybrid Sleeping Beauty: baculovirus vector for sustained gene expression and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus as a gene delivery vector for cartilage and bone tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Osteogenic differentiation of adipose-derived stem cells and calvarial defect repair using baculovirus-mediated co-expression of BMP-2 and miR-148b

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

The use of ASCs engineered to express BMP2 or TGF-β3 within scaffold constructs to promote calvarial bone repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Combination of baculovirus-expressed BMP-2 and rotating-shaft bioreactor culture synergistically enhances cartilage formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Combination of baculovirus-mediated gene transfer and rotating-shaft bioreactor for cartilage tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus as an expression and/or delivery vehicle for vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus as vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

A recombinant anchorless respiratory syncytial virus (RSV) fusion (F) protein/monophosphoryl lipid A (MPL) vaccine protects against RSV-induced replication and lung pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Recombinant vaccines for hepatitis E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Recombinant FAdV-4 fiber-2 protein protects chickens against hepatitis-hydropericardium syndrome (HHS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Rabies virus nucleoprotein expressed in silkworm pupae at high-levels and evaluation of immune responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Virus-like particles in vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Recombinant baculoviruses as expression vectors for insect and mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Enhanced papillomavirus-like particle production in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Norovirus vaccine against experimental human Norwalk Virus illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Immunogenicity of virus-like particles containing modified goose parvovirus VP2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Recombinant canine parvovirus-like particles express foreign epitopes in silkworm pupae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Canine parvovirus VP2 protein expressed in silkworm pupae self-assembles into virus-like particles with high immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Influenza vaccines based on virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

A recombinant viruslike particle influenza A (H7N9) vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Virus-like particle vaccine protects against H3N2 canine influenza virus in dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Protection against lethal challenge by Ebola virus-like particles produced in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Comparison of the efficacy of rotavirus VLP vaccines to a live homologous rotavirus vaccine in a pig model of rotavirus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

An oral versus intranasal prime/boost regimen using attenuated human rotavirus or VP2 and VP6 virus-like particles with immunostimulating complexes influences protection and antibody-secreting cell responses to rotavirus in a neonatal gnotobiotic pi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Chimeric infectious bursal disease virus-like particles expressed in insect cells and purified by immobilized metal affinity chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Effective chikungunya virus-like particle vaccine produced in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Enhanced production of Chikungunya virus-like particles using a high-pH adapted spodoptera frugiperda insect cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Development of enterovirus 71 vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Expression, purification and characterization of enterovirus-71 virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Evaluation of the stability of enterovirus 71 virus-like particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Characterization of recombinant foot-and-mouth disease virus pentamer-like structures expressed by baculovirus and their use as diagnostic antigens in a blocking ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Development of a liquid-phase blocking ELISA based on foot-and-mouth disease virus empty capsid antigen for seromonitoring vaccinated animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Clathrin-independent entry of baculovirus triggers uptake of E. coli in non-phagocytic human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Autographa californica multicapsid nucleopolyhedrovirus efficiently infects Sf9 cells and transduces mammalian cells via direct fusion with the plasma membrane at low pH

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

6-o- and N-sulfated syndecan-1 promotes baculovirus binding and entry into Mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Cell susceptibility to baculovirus transduction and echovirus infection is modified by protein kinase C phosphorylation and vimentin organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus capsid display: a novel tool for transduction imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Visualization of intracellular pathways of engineered baculovirus in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Self-biotinylation and site-specific double labeling of baculovirus using quantum dots for single-virus in-situ tracking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Labeling the nucleocapsid of enveloped baculovirus with quantum dots for single-virus tracking

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Host innate immune responses induced by baculovirus in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus induces type I interferon production through toll-like receptor-dependent and -independent pathways in a cell-type-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus transduction of mesenchymal stem cells triggers the toll-like receptor 3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Innate immune response induced by baculovirus attenuates transgene expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Use of the piggyBac transposon to create HIV-1 gag transgenic insect cell lines for continuous VLP production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Co-inoculation of baculovirus and FMDV vaccine in mice, elicits very early protection against foot and mouth disease virus without interfering with long lasting immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus display: a multifunctional technology for gene delivery and eukaryotic library development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Display of heterologous proteins on gp64null baculovirus virions and enhanced budding mediated by a vesicular stomatitis virus G-stem construct

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

New baculovirus recombinants expressing Pseudorabies virus (PRV) glycoproteins protect mice against lethal challenge infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

BacMam virus-based surface display of the infectious bronchitis virus (IBV) S1 glycoprotein confers strong protection against virulent IBV challenge in chickens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Induction of robust immunity response in mice by dual-expression-system-based recombinant baculovirus expressing the capsid protein of porcine circovirus type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Construction and immunogenicity of pseudotype baculovirus expressing GP5 and M protein of porcine reproductive and respiratory syndrome virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Enhanced immunogenicity induced by an alphavirus replicon-based pseudotyped baculovirus vaccine against porcine reproductive and respiratory syndrome virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Development of a novel viral DNA vaccine against human papillomavirus: AcHERV-HP16L1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Preclinical pharmacokinetics and biodistribution of human papillomavirus DNA vaccine delivered in human endogenous retrovirus envelope-coated baculovirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Immunogenicity of bivalent human papillomavirus DNA vaccine using human endogenous retrovirus envelope-coated baculoviral vectors in mice and pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Immunogenicity of a trivalent human papillomavirus L1 DNA-encapsidated, non-replicable baculovirus nanovaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Developments in the use of baculoviruses for the surface display of complex eukaryotic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus-based nasal drop vaccine confers complete protection against malaria by natural boosting of vaccine-induced antibodies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Hemagglutinin Displayed Baculovirus Protects Against Highly Pathogenic Influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus surface display of sigmaC and sigmaB proteins of avian reovirus and immunogenicity of the displayed proteins in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus surface display of E(rns) envelope glycoprotein of classical swine fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus surface display of E2 envelope glycoprotein of classical swine fever virus and immunogenicity of the displayed proteins in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus surface display of NS3 nonstructural protein of classical swine fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus surface display of E envelope glycoprotein of Japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

A baculovirus dual expression system-based vaccine confers complete protection against lethal challenge with H9N2 avian influenza virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus as an avian influenza vaccine vector: differential immune responses elicited by different vector forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus vector as an avian influenza vaccine: hemagglutinin expression and presentation augment the vaccine immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Rabies-virus-glycoprotein-pseudotyped recombinant baculovirus vaccine confers complete protection against lethal rabies virus challenge in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

A baculovirus dual expression system-based malaria vaccine induces strong protection against Plasmodium berghei sporozoite challenge in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Protective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Localization of VP28 on the baculovirus envelope and its immunogenicity against white spot syndrome virus in Penaeus monodon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

In vitro and in vivo RNA interference mediated suppression of Tn-caspase-1 for improved recombinant protein production in High Five cell culture with the baculovirus expression vector system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

A novel baculovirus vector shows efficient gene delivery of modified porcine reproductive and respiratory syndrome virus antigens and elicits specific immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 Influenza A virus induces protective immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Engineering of baculovirus vectors for the manufacture of virion-free biopharmaceuticals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

MicroRNAome of Spodoptera frugiperda cells (Sf9) and its alteration following baculovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Biosafety assessment of human mesenchymal stem cells engineered by hybrid baculovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Defective antiviral responses of induced pluripotent stem cells to baculoviral vector transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Xenotransplantation of human mesenchymal stem cells into immunocompetent rats for calvarial bone repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

How to avoid complement attack in baculovirus-mediated gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Polyethylenimine coating to produce serum-resistant baculoviral vectors for in vivo gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Microfibers fabricated by non-covalent assembly of peptide and DNA for viral vector encapsulation and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

A nanobiohybrid complex of recombinant baculovirus and Tat/DNA nanoparticles for delivery of Ang-1 transgene in myocardial infarction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

PAMAM dendrimer-baculovirus nanocomplex for microencapsulated adipose stem cell-gene therapy: in vitro and in vivo functional assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Induction of long-term protective immune responses by influenza H5N1 virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

BacMam immunization partially protects pigs against sublethal challenge with African swine fever virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

A pseudotype baculovirus expressing the capsid protein of foot-and-mouth disease virus and a T-cell immunogen shows enhanced immunogenicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Induction of antigen-specific immune responses in mice by recombinant baculovirus expressing premembrane and envelope proteins of West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus as a PRRSV and PCV2 bivalent vaccine vector: baculovirus virions displaying simultaneously GP5 glycoprotein of PRRSV and capsid protein of PCV2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Immune responses induced by a BacMam virus expressing the E2 protein of classical swine fever virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Oral vaccination of baculovirus-expressed VP28 displays enhanced protection against White Spot Syndrome Virus in Penaeus monodon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Baculovirus vector for gene delivery and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.951637

10.1586/14760584.2014.951637

21 January 2018

Identifiers

DOI

1 reference

release_wrz777g6q5bilgfyvpigjt3zhq

31 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wrz777g6q5bilgfyvpigjt3zhq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference